Wolfgang Wrasidlo
- Neurology top 5%
- Parkinson's Disease Mechanisms and Treatments 6
- Biomaterials top 5%
- Organic Chemistry top 5%
- Cyclization and Aryne Chemistry 9
- Synthetic Organic Chemistry Methods 6
- Oncology top 5%
- Cancer Treatment and Pharmacology 10
- Immunology top 10%
- Immune Response and Inflammation 4
-
- Bioactive Compounds and Antitumor Agents 5
-
- Microtubule and mitosis dynamics 5
-
- Nuclear Receptors and Signaling 4
- Co-authors
- K. C. NicolaouDavid A. ChereshWei‐Min DaiS.‐C. TSAYVirginia A. EstevezSara M. WeisMilan MakaleEliezer Masliah
- Journals
- Science (1 paper)Proceedings of the National Academy of Sciences (6 papers)Journal of the American Chemical Society (1 paper)
- Partner nations
- United StatesGermanyIsrael
In The Last Decade
Wolfgang Wrasidlo
56 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 113
- Neurology 417
- Biomaterials 298
- Organic Chemistry 632
- Oncology 556
- Immunology 407
Countries citing papers authored by Wolfgang Wrasidlo
This map shows the geographic impact of Wolfgang Wrasidlo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wolfgang Wrasidlo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wolfgang Wrasidlo more than expected).
Fields of papers citing papers by Wolfgang Wrasidlo
This network shows the impact of papers produced by Wolfgang Wrasidlo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wolfgang Wrasidlo. The network helps show where Wolfgang Wrasidlo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wolfgang Wrasidlo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2021 | 6 | |
| 4 | 2018 | 11 | |
| 5 | 2018 | 117 | |
| 6 | 2015 | 19 | |
| 7 | 2014 | 29 | |
| 8 | 2013 | 43 | |
| 9 | 2012 | 139 | |
| 10 | 2011 | 54 | |
| 11 | 2011 | 322 | |
| 12 | 2008 | 86 | |
| 13 | 2006 | 108 | |
| 14 | 2003 | 8 | |
| 15 | 2001 | 28 | |
| 16 | Targeted therapy of experimental renal cell carcinoma with a novel conjugate of monoclonal antibody 138H11 and calicheamicin thetaI1. | 2000 | 21 |
| 17 | 1995 | 6 | |
| 18 | 1994 | 24 | |
| 19 | 1994 | 48 | |
| 20 | 1994 | 39 |
About Wolfgang Wrasidlo
Wolfgang Wrasidlo is a scholar working on Toxicology, Organic Chemistry and Oncology, having authored 58 papers that have together received 2.8k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (10 papers), Cyclization and Aryne Chemistry (9 papers), Parkinson's Disease Mechanisms and Treatments (6 papers), Synthetic Organic Chemistry Methods (6 papers), Bioactive Compounds and Antitumor Agents (5 papers), Microtubule and mitosis dynamics (5 papers), Immune Response and Inflammation (4 papers) and Nuclear Receptors and Signaling (4 papers). The work is most often cited by research in Neurology (417 citations), Biomaterials (298 citations) and Organic Chemistry (632 citations). Wolfgang Wrasidlo has collaborated with scholars based in United States, Germany and Israel. Frequent co-authors include K. C. Nicolaou, David A. Cheresh, Wei‐Min Dai, S.‐C. TSAY, Virginia A. Estevez, Sara M. Weis, Milan Makale, Eliezer Masliah, Bharat K. Majeti and Eric A. Murphy. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.